These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27367271)

  • 1. Comparison of three different conjugation strategies in the construction of herceptin-bearing paclitaxel-loaded nanoparticles.
    Yu K; Zhou Y; Li Y; Sun X; Sun F; Wang X; Mu H; Li J; Liu X; Teng L; Li Y
    Biomater Sci; 2016 Aug; 4(8):1219-32. PubMed ID: 27367271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
    Yu K; Zhao J; Zhang Z; Gao Y; Zhou Y; Teng L; Li Y
    Int J Pharm; 2016 Jan; 497(1-2):78-87. PubMed ID: 26617314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery.
    Liu Y; Li K; Liu B; Feng SS
    Biomaterials; 2010 Dec; 31(35):9145-55. PubMed ID: 20864169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herceptin-conjugated paclitaxel loaded PCL-PEG worm-like nanocrystal micelles for the combinatorial treatment of HER2-positive breast cancer.
    Peng J; Chen J; Xie F; Bao W; Xu H; Wang H; Xu Y; Du Z
    Biomaterials; 2019 Nov; 222():119420. PubMed ID: 31445322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend.
    Zhao J; Mi Y; Liu Y; Feng SS
    Biomaterials; 2012 Feb; 33(6):1948-58. PubMed ID: 22153869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of in vitro phagocytic uptake and immunogenicity potential of modified Herceptin
    Badkas A; Frank E; Zhou Z; Jafari M; Chandra H; Sriram V; Lee JY; Yadav JS
    Colloids Surf B Biointerfaces; 2018 Feb; 162():271-278. PubMed ID: 29216514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles.
    Lee AL; Wang Y; Cheng HY; Pervaiz S; Yang YY
    Biomaterials; 2009 Feb; 30(5):919-27. PubMed ID: 19042015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells.
    Mattu C; Pabari RM; Boffito M; Sartori S; Ciardelli G; Ramtoola Z
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):463-72. PubMed ID: 23916461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of PEG tethering chain length of vitamin E TPGS with a Herceptin-functionalized nanoparticle formulation for targeted delivery of anticancer drugs.
    Zhao J; Feng SS
    Biomaterials; 2014 Mar; 35(10):3340-7. PubMed ID: 24461325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
    Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W
    Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery.
    Zhou Z; Badkas A; Stevenson M; Lee JY; Leung YK
    Int J Pharm; 2015 Jun; 487(1-2):81-90. PubMed ID: 25865568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
    Zeng N; Hu Q; Liu Z; Gao X; Hu R; Song Q; Gu G; Xia H; Yao L; Pang Z; Jiang X; Chen J; Fang L
    Int J Pharm; 2012 Mar; 424(1-2):58-66. PubMed ID: 22240390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herceptin-functionalized pure paclitaxel nanocrystals for enhanced delivery to HER2-postive breast cancer cells.
    Noh JK; Naeem M; Cao J; Lee EH; Kim MS; Jung Y; Yoo JW
    Int J Pharm; 2016 Nov; 513(1-2):543-553. PubMed ID: 27686050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
    Parveen S; Sahoo SK
    Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new application of plant virus nanoparticles as drug delivery in breast cancer.
    Esfandiari N; Arzanani MK; Soleimani M; Kohi-Habibi M; Svendsen WE
    Tumour Biol; 2016 Jan; 37(1):1229-36. PubMed ID: 26286831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agents.
    Liu Y; Mi Y; Zhao J; Feng SS
    Int J Pharm; 2011 Dec; 421(2):370-8. PubMed ID: 22001536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer.
    Mi Y; Zhao J; Feng SS
    J Control Release; 2013 Aug; 169(3):185-92. PubMed ID: 23403395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells.
    Cirstoiu-Hapca A; Buchegger F; Bossy L; Kosinski M; Gurny R; Delie F
    Eur J Pharm Sci; 2009 Oct; 38(3):230-7. PubMed ID: 19632322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.
    Shenoy D; Little S; Langer R; Amiji M
    Mol Pharm; 2005; 2(5):357-66. PubMed ID: 16196488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.